Theranos Caves To Critics, Agrees To Release Data On Its Blood Tests

Theranos CEO Elizabeth Holmes said the company will publish data disproving allegations made by the Wall Street Journal.

After weathering a severe bout of bad press, medical startup Theranos is embracing transparency: On Monday, CEO Elizabeth Holmes said the company will soon publish data that she claims will demonstrate the accuracy of Theranos blood tests. Following the publication of two critical articles in the Wall Street Journal last week, Theranos fell under heavy scrutiny, due to claims that its technology was only used for a limited number of tests, and that the results of its blood tests were unreliable.

Read Full Story